[Federal Register Volume 67, Number 236 (Monday, December 9, 2002)]
[Notices]
[Page 72965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-30959]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: ``Coil for Transcranial 
Magnetic Stimulation''

AGENCY: National Institutes of Health, Public Health Service, DHHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a public notice, in accordance with 35 U.S.C. 
209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of 
Health (NIH), Department of Health and Human Services, is contemplating 
the grant of an exclusive license worldwide to practice the inventions 
embodied in:

Employee Invention Report E-223-00/0, ``Coil for Magnetic 
Stimulation,'' PCT Application No. PCT/US01/50737 by Zangen et al.
to BrainGate, Inc., having a place of business at 25883 Goose Neck Rd, 
Royal Oak, MD 21662.
    The United States of America is the assignee to the patent rights 
of these inventions.
    The contemplated exclusive license may be restricted to the fields 
of Transcranial Magnetic Stimulation (TMS) therapies and apparatus.

DATES: Only written comments and/or applications for a license that are 
received by the NIH Office of Technology Transfer on or before February 
7, 2003, will be considered.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments and other materials relating to the contemplated license 
should be directed to: Dale D. Berkley, Ph.D., J.D. Technology 
Licensing Specialist, Office of Technology Transfer, National 
Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, 
MD 20852-3804; Telephone: (301) 435-5019; Facsimile: (301) 402-0220; E-
mail: [email protected]. A signed confidential disclosure agreement 
will be required to receive copies of the patent application.

SUPPLEMENTARY INFORMATION: The invention is a magnetic stimulator that 
is placed in contact with the head of a subject to magnetically 
stimulate the brain. The device has applications in the treatment of 
cardiovascular or neurophysiological conditions, and may be of 
particular utility in the treatment of disorders associated with deep 
regions of the brain, such as drug addiction and depression. The unique 
coil shape of the stimulator is designed to target the nucleus 
accumbens, a region deep within the brain associated with the 
biological mechanism underlying drug abuse. Deep regions of the brain 
are also implicated in depressive disorders, and this coil is likely to 
offer an improvement in the transcranial magnetic stimulation therapy 
currently being tested for treatment of depression.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. 
The prospective exclusive license may be granted unless, within 60 days 
from the date of this published notice, NIH receives written evidence 
and argument that establishes that the grant of the license would not 
be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    Properly filed competing applications for a license filed in 
response to this notice will be treated as objections to the 
contemplated license. Comments and objections submitted in response to 
this notice will not be made available for public inspection, and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act, 5 U.S.C. 552.

    Dated: November 29, 2002.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer.
[FR Doc. 02-30959 Filed 12-5-02; 8:45 am]
BILLING CODE 4140-01-P